EditCo Bio, Inc. Launches XDel Knockout Cells: Redefining CRISPR Gene Editing Efficiency and Reproducibility
REDWOOD CITY, Calif., Jan. 29, 2025 /BUSINESS WIRE/ — EditCo Bio, a leader in cutting-edge genetic engineering and cellular model solutions, today announced the launch of XDel Knockout Cells, an innovative product designed to revolutionize the field of CRISPR gene editing. By leveraging a groundbreaking guide RNA (gRNA) design strategy, XDel technology ensures robust, reliable, and reproducible gene knockout results that accelerate research in functional genomics, disease modeling, and drug development.
Ramona Unveils Vireo™: The World’s Fastest Live-Cell Imaging System
DURHAM, N.C., Jan. 15, 2025 /PRNewswire/ — Ramona introduces groundbreaking Vireo™ live-cell imaging system, delivering 10x faster analysis for drug discovery workflows.
AGC Biologics to Manufacture LVV for CAR-T Therapy Approved by FDA for Autolus Therapeutics’ AUCATZYL®
AGC Biologics partners with Autolus Therapeutics to manufacture FDA-approved lentiviral vectors (LVV) for advanced CAR-T cancer therapies.
Ambient Biosciences Seeks Early Access Program Partners to Trial Room Temperature Stabilization Technology for Biomolecules and Reagents
Ambient Biosciences invites partners for trials of its room-temperature stabilization technology, revolutionizing biomolecule and reagent storage.
Jura Health and Samba Scientific partner to improve genomic testing access to underserved populations
Jura Health and Samba Scientific join forces to enhance genomic testing accessibility for underserved populations, driving health equity.
CMC Pharma Subcontracted for Nerve Agent Countermeasure Development Program by Battelle and the U.S. Department of Defense
Discover how CMC Pharma is advancing nerve agent defense solutions with its growing portfolio of innovative medical countermeasures.
Broad Clinical Labs and Genomes2Veterans Partner on Veterans Affairs’ Prostate Cancer, Genetic Risk, and Equitable Screening Study (ProGRESS)
Broad Clinical Labs and Genomes2Veterans join forces to advance prostate cancer genetic risk research and equitable screening for veterans.
AGC Biologics Seattle Achieves Approval for all 2024 Biologics License Applications from U.S. Food and Drug Administration, Concluding Pre-License Inspection
AGC Biologics’ Seattle facility achieves approval for three BLAs, showcasing excellence in biopharmaceutical manufacturing and innovation.
Adare Pharma, Laxxon Partner to Advance 3D Printed Oral Dosage Forms
Adare Pharma and Laxxon team up to innovate 3D-printed oral dosage forms, advancing precision medicine and patient care solutions.
Circular Genomics Announces Launch of MindLight™, the First SSRI Antidepressant Response Test Using Brain-Derived Biomarkers
Discover MindLight by Circular Genomics, the innovative SSRI response test transforming personalized antidepressant treatment.
